Talk:Raymond Schinazi

Contributions to sofosbuvir
Schinazi's contribution to the discovery of sofosbuvir is contentious. He is the co-author of a 2005 paper that discovered a precursor to the drug. Jean-Pierre Sommadossi, a principal founder of Idenix and a co-founder of Pharmasset, has stated that Schinazi “wasn't involved with anything” in the actual development of sofosbuvir. Schinazi's former business partner no longer speaks to him.
 * Previous material violates Wikipedia Policy. The point of view was not neutral and the statements are not well sourced. One statement is merely opinion. Selected fragments of source material have been taken and are presented in a contentious manner to disparage. Other non-disparaging source material was not provided.